Technical Analysis for ATRS - Antares Pharma, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Flat |
| Historical ATRS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Bollinger Band Squeeze | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| 20 DMA Resistance | Bearish | 1.72% | |
| Pocket Pivot | Bullish Swing Setup | 1.72% | |
| Bollinger Band Squeeze | Range Contraction | 1.72% | |
| Outside Day | Range Expansion | 1.72% | |
| Bollinger Band Squeeze | Range Contraction | 2.23% | |
| Down 3 Days in a Row | Weakness | 2.23% | |
| Bollinger Band Squeeze | Range Contraction | 1.47% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| 20 DMA Resistance | about 18 hours ago |
| 10 DMA Resistance | about 18 hours ago |
| Rose Above 20 DMA | about 19 hours ago |
| Rose Above 10 DMA | about 19 hours ago |
| Up 2% | about 19 hours ago |
Get a Trading Sidekick!
- Earnings date: 11/05/2020
Antares Pharma, Inc. Description
Antares Pharma, Inc. operates as a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies, and topical gel-based medicines worldwide. The company's products include Tjet/Zomajet, the needle-free auto injectors to deliver human growth hormone treatment to children without the use of a needle; twin-jector EZ II needle free injectors; Medi-Jet auto injectors; Elestrin, an estrogen replacement gel for the treatment of hot flashes; and Gelnique 3%, an oxybutynin gel product for the treatment of overactive bladder. The company is also developing OTREXUP, a product for the delivery of methotrexate using Medi-Jet technology for the treatment of rheumatoid arthritis, poly-articular-course juvenile rheumatoid arthritis, and psoriasis; and VIBEX QS T, an auto injector for the treatment of testosterone deficiency or replacement therapy. In addition, it is developing Vibex auto injectors; disposable pen injectors; and Nestragel, a contraceptive gel. Antares Pharma, Inc. has collaborative and license agreements with Ferring Pharmaceuticals BV; Teva Pharmaceutical Industries, Ltd.; JCR Pharmaceuticals Co., Ltd.; Actavis, Inc.; Daewoong Pharmaceuticals; BioSante Pharmaceuticals, Inc.; Meda Pharmaceuticals; Population Council; and Pfizer Inc. The company was founded in 1979 and is headquartered in Ewing, New Jersey.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Biotechnology Pharmaceutical Pharmaceutical Products Medical Equipment Pharmacology Flash Rheumatoid Arthritis Psoriasis Pharmaceutical Industries Injector Estrogen Growth Hormone Testosterone Hot Flash Teva Pharmaceutical Industries Methotrexate Overactive Bladder Testosterone Deficiency
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 5.06 |
| 52 Week Low | 2.39 |
| Average Volume | 1,221,316 |
| 200-Day Moving Average | 3.46 |
| 50-Day Moving Average | 4.32 |
| 20-Day Moving Average | 4.12 |
| 10-Day Moving Average | 4.11 |
| Average True Range | 0.15 |
| ADX | 16.15 |
| +DI | 14.39 |
| -DI | 16.34 |
| Chandelier Exit (Long, 3 ATRs ) | 4.03 |
| Chandelier Exit (Short, 3 ATRs ) | 4.34 |
| Upper Bollinger Band | 4.30 |
| Lower Bollinger Band | 3.93 |
| Percent B (%b) | 0.54 |
| BandWidth | 8.85 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.06 |
| MACD Histogram | 0.0072 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.24 | ||||
| Resistance 3 (R3) | 4.24 | 4.20 | 4.22 | ||
| Resistance 2 (R2) | 4.20 | 4.18 | 4.20 | 4.21 | |
| Resistance 1 (R1) | 4.17 | 4.16 | 4.19 | 4.17 | 4.21 |
| Pivot Point | 4.13 | 4.13 | 4.14 | 4.13 | 4.13 |
| Support 1 (S1) | 4.10 | 4.11 | 4.11 | 4.09 | 4.05 |
| Support 2 (S2) | 4.06 | 4.09 | 4.06 | 4.05 | |
| Support 3 (S3) | 4.03 | 4.06 | 4.04 | ||
| Support 4 (S4) | 4.02 |
